OpenURL Connection Search

Select item for more details and to access through your institution.

CSF proteomics analysis to investigate the pharmacodynamic response of the S2R modulator CT1812 in Alzheimer's disease patients from the SPARC clinical trial.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068166
By:
- Pandey, Kiran;
- Waybright, Lora;
- Duong, Duc M.;
- Malagise, Evi;
- Blennow, Kaj;
- Zetterberg, Henrik;
- Mecca, Adam P;
- van Dyck, Christopher H;
- Caggiano, Anthony O;
- Seyfried, Nicholas T.;
- Hamby, Mary E
Publication type:
Article
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 8, p. 1365, doi. 10.1002/alz.12302
By:
- Izzo, Nicholas J.;
- Yuede, Carla M.;
- LaBarbera, Kelsie M.;
- Limegrover, Colleen S.;
- Rehak, Courtney;
- Yurko, Raymond;
- Waybright, Lora;
- Look, Gary;
- Rishton, Gilbert;
- Safferstein, Hank;
- Hamby, Mary E.;
- Williams, Claire;
- Sadlek, Kelsey;
- Edwards, Hannah M.;
- Davis, Charles S.;
- Grundman, Michael;
- Schneider, Lon S.;
- DeKosky, Steven T.;
- Chelsky, Daniel;
- Pike, Ian
Publication type:
Article
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease.
Published in:
Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02679-6
By:
- Colom-Cadena, Martí;
- Toombs, Jamie;
- Simzer, Elizabeth;
- Holt, Kristjan;
- McGeachan, Robert;
- Tulloch, Jane;
- Jackson, Rosemary J.;
- Catterson, James H.;
- Spires-Jones, Maxwell P.;
- Rose, Jamie;
- Waybright, Lora;
- Caggiano, Anthony O.;
- King, Declan;
- Gobbo, Francesco;
- Davies, Caitlin;
- Hooley, Monique;
- Dunnett, Sophie;
- Tempelaar, Robert;
- Meftah, Soraya;
- Tzioras, Makis
Publication type:
Article
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
Published in:
2023
By:
- LaBarbera, Kelsie M.;
- Sheline, Yvette I.;
- Izzo, Nicholas J.;
- Yuede, Carla M.;
- Waybright, Lora;
- Yurko, Raymond;
- Edwards, Hannah M.;
- Gardiner, Woodrow D.;
- Blennow, Kaj;
- Zetterberg, Henrik;
- Börjesson-Hanson, Anne;
- Morgan, Roger;
- Davis, Charles S.;
- Guttendorf, Robert J.;
- Schneider, Lon S.;
- DeKosky, Steven;
- LeVine III, Harry;
- Grundman, Michael;
- Caggiano, Anthony O.;
- Cirrito, John R.
Publication type:
Abstract

Found: 4

CSF proteomics analysis to investigate the pharmacodynamic response of the S2R modulator CT1812 in Alzheimer's disease patients from the SPARC clinical trial.

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.

Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease.

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.